Document is current

Article History

Received: 11 July 2025

Accepted: 11 August 2025

First Online: 30 August 2025

Declarations

:

: Laura Ackermann, Daniel Zeller, Thorsten Odorfer, György A. Homola, Thomas Kampf, Mirko Pham, Hans-Christoph Aster and Claudia Sommer have no conflict of interest to declare. Thorsten Odorfer has consulted for TEVA. Daniel Zeller has consulted for Novartis and has been on the Advisory board of Biogen. He has given a talk for Angelini Pharma and received travel compensation. Claudia Sommer has given educational talks for Alnylam, argenx, CSL Behring, Grifols, GSK, Kedrion, Novartis, Pfizer, Takeda, TEVA. She has consulted for Akigai, Algiax, Annexon, argenx, Bayer, CSL-Behring, Grifols, Kedrion, Nevro, Sanofi, Takeda, TEVA. Claudia Sommer is an Editorial Board member of Pain and Therapy and deputy editor of the European Journal of Neurology. She was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Laura Ackermann, György A. Homola, Thomas Kampf, Mirko Pham and Hans-Christoph Aster have nothing to disclose. Laura Ackermann changed her affiliation during the completion of the manuscript to the Department of Oto-Rhino-Laryngology, Head and Neck Surgery of the University Hospital Würzburg.

: All patients gave written informed consent to the study according to the Declaration of Helsinki. The Ethics Committee of the University of Würzburg Medical Faculty approved the study (140/19).